Kevin Hsu, DPM
Foot & Ankle Surgery · Effingham, ILNPI 1417567538
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 39.1% of the total. 2025 is the largest year on record at $430, more than ten times the $23 reported in 2022. That places this record below the midpoint for foot & ankle surgery clinicians in IL, where the typical reported total is $2,398.
Across 49 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$365
- GSK$118
- Polynovo North America LLC$90
- Amgen$63
- Kerecis Limited$48
- Axogen$42
- plus $209 from 8 others
What the payments were for
- Food & beverage$934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 21 | $365 |
| GSK | 6 | $118 |
| Polynovo North America LLC | 3 | $90 |
| Amgen(2 entities) | 3 | $63 |
| Kerecis Limited | 3 | $48 |
| Axogen | 1 | $42 |
| Bioventus LLC | 2 | $37 |
| Integra Lifesciences Corporation | 2 | $35 |
| Organogenesis Inc. | 2 | $34 |
| Stryker | 2 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Biocomposites Inc | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $10 |
How this compares
$934 in reported general payments places this provider in the 30th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 42 | $1,243 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 44 | $452 |
| Celecoxib | 13 | $295 |
| Ammonium Lactate | 15 | $282 |
| Ciclopirox | 11 | $277 |
| Clindamycin Hcl | 11 | $173 |
| Naproxen | 21 | $140 |
| Methylprednisolone | 14 | $99 |
| Terbinafine Hcl | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Effingham
- Douglas PacaccioRockford$4.1M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.2M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$570K
- Brian BurgessNaperville$488K
- Kyle PearsonMorris$208K
- Stephanie OexemanChicago$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.